Works by Xu, Benling

Results: 14

Utility of the neutrophil-to-lymphocyte ratio and the ratio of neutrophil-to-lymphocyte ratio after and before adverse events for differential diagnosis of immune-related adverse events and bacterial infections in cancer patients treated with PD-(L)1 inhibitors

Published in:

Journal of Leukocyte Biology, 2025, v. 117, n. 5, p. 1, doi. 10.1093/jleuko/qiaf029

By:

Han, Lu;
Huang, Beibei;
Li, Linlin;
Xu, Benling;
Yang, Yonghao;
Zhao, Lingdi;
Wang, Zibing;
Zhang, Chaoji;
Gao, Quanli

Publication type:

Article

Ki-67 expression in luminal type breast cancer and its association with the clinicopathology of the cancer.

Published in:

Oncology Letters, 2016, v. 11, n. 3, p. 2101, doi. 10.3892/ol.2016.4199

By:

PENG YUAN;
BENLING XU;
CHENGZHENG WANG;
CHENGJUAN ZHANG;
MIAOMIAO SUN;
LONG YUAN

Publication type:

Article

Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy.

Published in:

Technology in Cancer Research & Treatment, 2021, v. 20, p. 1, doi. 10.1177/15330338211034291

By:

Jia, Wangqiang;
Yuan, Long;
Ni, Hongyan;
Xu, Benling;
Zhao, Peng

Publication type:

Article

Potential predictive value of CD8A and PGF protein expression in gastric cancer patients treated with neoadjuvant immunotherapy.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14046-7

By:

Zhang, Chengjuan;
Wang, Tingjie;
Yuan, Jing;
Wang, Tao;
Ma, Bin;
Xu, Benling;
Bai, Ruihua;
Tang, Xiance;
Zhang, Xiaojie;
Wu, Minqing;
Lei, Tianqi;
Xu, Wenhao;
Guo, Yongjun;
Li, Ning

Publication type:

Article

The role of intestinal flora on tumorigenesis, progression, and the efficacy of PD-1/PD-L1 antibodies in colorectal cancer.

Published in:

Cancer Biology & Medicine, 2024, v. 21, n. 1, p. 65, doi. 10.20892/j.issn.2095-3941.2023.0376

By:

Sen Wang;
Benling Xu;
Yangyang Zhang;
Guangyu Chen;
Peng Zhao;
Quanli Gao;
Long Yuan

Publication type:

Article

Combination therapy using low‐dose anlotinib and immune checkpoint inhibitors for extensive‐stage small cell lung cancer.

Published in:

Cancer Innovation, 2024, v. 3, n. 6, p. 1, doi. 10.1002/cai2.155

By:

Li, Han;
Yuan, Shumin;
Wu, Han;
Wang, Yajie;
Ma, Yichen;
Tang, Xiance;
Fu, Xiaomin;
Zhao, Lingdi;
Xu, Benling;
Li, Tiepeng;
Qin, Peng;
You, Hongqin;
Han, Lu;
Wang, Zibing

Publication type:

Article

589. Construction and Antiproliferative Effect of mc-γIFNs

Published in:

2005

By:

Wu, Jiangxue;
Huang, Bijun;
Xu, Benling;
Xue, Gang

Publication type:

Abstract

Sulforaphene induces apoptosis and inhibits the invasion of esophageal cancer cells through MSK2/CREB/Bcl-2 and cadherin pathway in vivo and in vitro.

Published in:

Cancer Cell International, 2019, v. 19, n. 1, p. 1, doi. 10.1186/s12935-019-1061-1

By:

Zhang, Chengjuan;
Zhang, Junxia;
Wu, Qiong;
Xu, Benling;
Jin, Guoguo;
Qiao, Yan;
Zhao, Simin;
Yang, Yang;
Shang, Jinwen;
Li, Xiaofang;
Liu, Kangdong

Publication type:

Article

S-15 in combination of Akt inhibitor promotes the expansion of CD45RA−CCR7+ tumor infiltrating lymphocytes with high cytotoxic potential and downregulating PD-1+Tim-3+ cells as well as regulatory T cells.

Published in:

Cancer Cell International, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12935-019-1043-3

By:

Xu, Benling;
Yuan, Long;
Chen, Guangyu;
Li, Tiepeng;
Zhou, Jinxue;
Zhang, Chengjuan;
Qin, Peng;
Muthana, Musleh M.;
Wang, Shengdian;
Du, Xuexiang;
Gao, Quanli

Publication type:

Article

The baseline circulating immunophenotype characteristics associate with PD(L)-1 targeted treatment response, irae onset, and prognosis.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-02597-5

By:

Fu, Xiaomin;
Li, Fanghui;
You, Hongqin;
Xu, Benling;
Wang, Tingjie;
Qin, Peng;
Han, Lu;
Zhang, Yong;
Zhang, Fang;
Zhao, Lingdi;
Ma, Baozhen;
Shang, Yiman;
Yang, Yonghao;
Wang, Zibing;
Qu, Jinrong;
Gao, Quanli

Publication type:

Article

Silencing of Ribosomal Protein L34 (RPL34) Inhibits the Proliferation and Invasion of Esophageal Cancer Cells.

Published in:

Oncology Research, 2017, v. 25, n. 7, p. 1061, doi. 10.3727/096504016X14830466773541

By:

Huijie Fan;
Jing Li;
Yongxu Jia;
Jingjing Wu;
Long Yuan;
Mingjun Li;
Jiangqi Wei;
Benling Xu

Publication type:

Article

High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center Study.

Published in:

Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.779248

By:

Lingdi Zhao;
Tiepeng Li;
Yongping Song;
Yonghao Yang;
Baozhen Ma;
Yong Zhang;
Yiman Shang;
Benling Xu;
Jindong Guo;
Peng Qin;
Lu Han;
Xiaomin Fu;
Hongwei Lin;
Liang Liu;
Xiubao Ren;
Zibing Wang;
Quanli Gao

Publication type:

Article

The inter-link of ageing, cancer and immunity: findings from real-world retrospective study.

Published in:

Immunity & Ageing, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12979-023-00399-9

By:

Fu, Xiaomin;
Qin, Peng;
Li, Fanghui;
Zhu, Huifang;
You, Hongqin;
Zhang, Yong;
Xu, Benling;
Li, Tiepeng;
Zhang, Fang;
Han, Lu;
Zhao, Lingdi;
Ma, Baozhen;
Wang, Zibing;
Gao, Quanli

Publication type:

Article

Tumor-infiltrating CD4+ T cells in patients with gastric cancer.

Published in:

Cancer Cell International, 2017, v. 17, p. 1, doi. 10.1186/s12935-017-0489-4

By:

Long Yuan;
Benling Xu;
Peng Yuan;
Jinxue Zhou;
Peng Qin;
Lu Han;
Guangyu Chen;
Zhenlei Wang;
Zengci Run;
Peng Zhao;
Quanli Gao

Publication type:

Article

Works by Xu, Benling

Utility of the neutrophil-to-lymphocyte ratio and the ratio of neutrophil-to-lymphocyte ratio after and before adverse events for differential diagnosis of immune-related adverse events and bacterial infections in cancer patients treated with PD-(L)1 inhibitors

Ki-67 expression in luminal type breast cancer and its association with the clinicopathology of the cancer.

Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy.

Potential predictive value of CD8A and PGF protein expression in gastric cancer patients treated with neoadjuvant immunotherapy.

The role of intestinal flora on tumorigenesis, progression, and the efficacy of PD-1/PD-L1 antibodies in colorectal cancer.

Combination therapy using low‐dose anlotinib and immune checkpoint inhibitors for extensive‐stage small cell lung cancer.

589. Construction and Antiproliferative Effect of mc-γIFNs

Sulforaphene induces apoptosis and inhibits the invasion of esophageal cancer cells through MSK2/CREB/Bcl-2 and cadherin pathway in vivo and in vitro.

S-15 in combination of Akt inhibitor promotes the expansion of CD45RA<sup>−</sup>CCR7<sup>+</sup> tumor infiltrating lymphocytes with high cytotoxic potential and downregulating PD-1<sup>+</sup>Tim-3<sup>+</sup> cells as well as regulatory T cells.

The baseline circulating immunophenotype characteristics associate with PD(L)-1 targeted treatment response, irae onset, and prognosis.

Silencing of Ribosomal Protein L34 (RPL34) Inhibits the Proliferation and Invasion of Esophageal Cancer Cells.

High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center Study.

The inter-link of ageing, cancer and immunity: findings from real-world retrospective study.

Tumor-infiltrating CD4<sup>+</sup> T cells in patients with gastric cancer.